Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai

[1] Sichero L(2017)Cervical infection with cutaneous Beta and Mucosal alpha papillomaviruses Cancer Epidemiol Biomark Prev 26 1312-1320

[2] El-Zein M(2018)Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61) Virology 516 86-101

[3] Nunes EM(2017)Worldwide burden of cancer attributable to HPV by site, country and HPV type Int J Cancer 141 664-670

[4] Ferreira S(2016)Carcinogenic human papillomavirus infection Nat Rev Dis Primers 2 16086-244

[5] Franco EL(2013)HPV16 genetic variation and the development of cervical cancer worldwide Br J Cancer 108 240-973

[6] Villa LL(2014)Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions PLoS One 9 e100746-1489

[7] Ludwig-McGill Cohort S(2016)HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women Journal of the National Cancer Institute 108 djw100-162

[8] Chen Z(2011)Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia Int J Cancer 129 965-1874

[9] Schiffman M(2017)E6 and E7 gene polymorphisms in human papillomavirus Types-58 and 33 identified in Southwest China PLoS One 12 e0171140-W572

[10] Herrero R(2018)Multiple routes to Oncogenesis are promoted by the human papillomavirus-host protein network Cancer Discov 8 1474-W241

[1] Sichero L(2017)Cervical infection with cutaneous Beta and Mucosal alpha papillomaviruses Cancer Epidemiol Biomark Prev 26 1312-1320

[2] El-Zein M(2018)Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61) Virology 516 86-101

[3] Nunes EM(2017)Worldwide burden of cancer attributable to HPV by site, country and HPV type Int J Cancer 141 664-670

[4] Ferreira S(2016)Carcinogenic human papillomavirus infection Nat Rev Dis Primers 2 16086-244

[5] Franco EL(2013)HPV16 genetic variation and the development of cervical cancer worldwide Br J Cancer 108 240-973

[6] Villa LL(2014)Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions PLoS One 9 e100746-1489

[7] Ludwig-McGill Cohort S(2016)HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women Journal of the National Cancer Institute 108 djw100-162

[8] Chen Z(2011)Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia Int J Cancer 129 965-1874

[9] Schiffman M(2017)E6 and E7 gene polymorphisms in human papillomavirus Types-58 and 33 identified in Southwest China PLoS One 12 e0171140-W572

[10] Herrero R(2018)Multiple routes to Oncogenesis are promoted by the human papillomavirus-host protein network Cancer Discov 8 1474-W241